Crossmark

Emergency holmium laser enucleation of the prostate (HoLEP): a novel approach in the management of refractory hematuria for patients with benign prostatic hyperplasia (BPH): a single-institution experience

Crossref DOI link: https://doi.org/10.1007/s00345-023-04292-4

Published Online: 2023-01-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elmansy, Hazem https://orcid.org/0000-0003-3601-4626
Hodhod, Amr

Fathy, Moustafa

Violette, Philippe D.

Elshafei, Ahmed

Zakaria, Ahmed S.

Kelly, Ryan

Rozenberg, Radu

Alaref, Amer

Abbas, Loay

Abdul Hadi, Ruba

Kotb, Ahmed

Shahrour, Walid
License Information

Text and Data Mining valid from 2023-01-28

Version of Record valid from 2023-01-28
More Information

Article History

Received: 6 October 2022

Accepted: 10 January 2023

First Online: 28 January 2023

Declarations

:

: No conflict of interest.

: The study was approved by our institutional research ethics committee (Northern Ontario School of Medicine) and certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

: The study has a retrospective nature where data are already available and no patients contact or further interviews are required.

Document is current

Any future updates will be listed below